Sullivan
Microsoft has discontinued support for Internet Explorer. To access the Sullivan website, please install a modern browser like Microsoft Edge or Google Chrome.

Biography

  • Represented Truliant Consulting, a leading pharmacovigilance, risk management, and regulatory compliance advisory firm, in connection with its acquisition by ELIQUENT Life Sciences
  • Represented KUDO, the cloud-based video conferencing platform with real-time multilingual interpretation in 100+ languages and 147 sign languages, on its $21M Series A Preferred Stock financing
  • Represented Somatix, a digital health company focused on remote patient monitoring, in connection with its Series A financing, convertible notes offering and day-to-day matters
  • Represented Rescue Hearing, a gene therapy company, in connection with its license to Myrtelle Inc. to develop a novel gene therapy for hearing loss
  • Represented DarioHealth (Nasdaq: DRIO), a digital therapeutics company, in connection with its $30 million acquisition of PsyInnovations, Inc., dba wayForward, a behavioral health digital platform
  • Represented Clear Genetics, a software company focused on integrating genetics into routine patient care, in connection with its $50 million acquisition by Invitae Corporaiton (NYSE: NVTA)
  • Represented 97212 Studio, an accelerator focused on supporting Israeli tech companies expanding to the United States, in connection with its formation and financing
  • Represented family offices in connection with their investments in venture funds, start-up companies and real estate
  • Represented many early-stage companies in connection with their formation, initial stockholder arrangements and seed financings

Matters

  • Represented Truliant Consulting, a leading pharmacovigilance, risk management, and regulatory compliance advisory firm, in connection with its acquisition by ELIQUENT Life Sciences
  • Represented KUDO, the cloud-based video conferencing platform with real-time multilingual interpretation in 100+ languages and 147 sign languages, on its $21M Series A Preferred Stock financing
  • Represented Somatix, a digital health company focused on remote patient monitoring, in connection with its Series A financing, convertible notes offering and day-to-day matters
  • Represented Rescue Hearing, a gene therapy company, in connection with its license to Myrtelle Inc. to develop a novel gene therapy for hearing loss
  • Represented DarioHealth (Nasdaq: DRIO), a digital therapeutics company, in connection with its $30 million acquisition of PsyInnovations, Inc., dba wayForward, a behavioral health digital platform
  • Represented Clear Genetics, a software company focused on integrating genetics into routine patient care, in connection with its $50 million acquisition by Invitae Corporaiton (NYSE: NVTA)
  • Represented 97212 Studio, an accelerator focused on supporting Israeli tech companies expanding to the United States, in connection with its formation and financing
  • Represented family offices in connection with their investments in venture funds, start-up companies and real estate
  • Represented many early-stage companies in connection with their formation, initial stockholder arrangements and seed financings

Matters